JAM
ABBV icon

Jolley Asset Management’s AbbVie ABBV Stock Holding History

Jolley Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.15M Buy
15,038
+150
+1% +$12.8K 0.88% 38
2019
Q4 		$1.32M Sell
14,888
-3,550
-19% -$295K 0.75% 38
2019
Q3 		$1.4M Buy
18,438
+1,900
+11% +$130K 0.91% 33
2019
Q2 		$1.2M Buy
16,538
+763
+5% +$60K 0.77% 35
2019
Q1 		$1.27M Buy
15,775
+1,623
+11% +$133K 0.92% 32
2018
Q4 		$1.3M Buy
14,152
+255
+2% +$22.4K 1% 33
2018
Q3 		$1.31M Sell
13,897
-3,920
-22% -$372K 0.88% 33
2018
Q2 		$1.65M Sell
17,817
-564
-3% -$55.1K 1.11% 32
2018
Q1 		$1.74M Sell
18,381
-53
-0.3% -$5.82K 1.05% 36
2017
Q4 		$1.78M Sell
18,434
-100
-0.5% -$9.43K 1.13% 34
2017
Q3 		$1.65M Sell
18,534
-155
-0.8% -$11.8K 1.12% 33
2017
Q2 		$1.35M Buy
18,689
+950
+5% +$63.9K 0.95% 35
2017
Q1 		$1.16M Sell
17,739
-280
-2% -$17.6K 0.83% 33
2016
Q4 		$1.13M Buy
18,019
+50
+0.3% +$3.05K 0.81% 34
2016
Q3 		$1.13M Hold
17,969
– – 0.92% 33
2016
Q2 		$1.11M Buy
17,969
+975
+6% +$59.4K 0.89% 35
2016
Q1 		$971K Buy
16,994
+2,642
+18% +$147K 0.88% 34
2015
Q4 		$850K Sell
14,352
-1,395
-9% -$80.3K 0.81% 34
2015
Q3 		$857K Hold
15,747
– – 0.87% 34
2015
Q2 		$1.06M Sell
15,747
-380
-2% -$24.8K 0.96% 32
2015
Q1 		$944K Sell
16,127
-670
-4% -$40.5K 0.78% 35
2014
Q4 		$1.1M Sell
16,797
-162
-1% -$10.2K 0.91% 32
2014
Q3 		$980K Sell
16,959
-1,425
-8% -$79.1K 0.79% 34
2014
Q2 		$1.04M Sell
18,384
-2,015
-10% -$106K 0.76% 35
2014
Q1 		$1.05M Sell
20,399
-2,365
-10% -$120K 0.78% 37
2013
Q4 		$1.2M Sell
22,764
-55
-0.2% -$2.7K 0.95% 33
2013
Q3 		$1.02M Sell
22,819
-150
-0.7% -$6.65K 0.85% 33
2013
Q2 		$950K Buy
+22,969
New +$1M 0.77% 36

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jolley Asset Management's ABBV Position: Q1 2020 in Review

Jolley Asset Management increased its AbbVie (ABBV) stake by 1% in Q1 2020, buying an estimated $12.8K and bringing the position to 15,038 shares worth $1.15M. The position accounts for 0.88% of the portfolio, ranked #38.

Jolley Asset Management first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. The position peaked at $1.78M in Q4 2017. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Jolley Asset Management held 15,038 shares of AbbVie worth $1.15M as of Q1 2020.
  • Jolley Asset Management bought 150 AbbVie shares in Q1 2020, an estimated $12.8K.
  • AbbVie made up 0.88% of Jolley Asset Management's portfolio in Q1 2020, its #38 holding.
  • Jolley Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
  • Jolley Asset Management's AbbVie position peaked at $1.78M in Q4 2017.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Jolley Asset Management's 13F filing for Q1 2020, filed 15 Apr 2020.